Physician profile
Rolando Ramirez
NPI 1063494458
$2,882.80
in general payments reported to CMS, 2019-2025
20 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,141 · 2022: $1,514 · 2023: $30.54 · 2024: $40.17 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $488.44 | 2021-2024 | |
| Amgen INC. | $410.51 | 2021-2025 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.27 | 2021-2022 | |
| Lilly USA, LLC | $303.76 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $224.80 | 2021-2022 | |
| Novo Nordisk INC | $219.68 | 2021-2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $181.50 | 2022 | |
| Merck Sharp & Dohme LLC | $132.87 | 2021-2025 | Capvaxive |
| Alexion Pharmaceuticals, INC. | $132.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $109.93 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $66.11 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $53.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.22 | 2021-2022 | |
| Exact Sciences Corporation | $35.27 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $32.66 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $22.10 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.48 | 2021 | |
| Sunovion Pharmaceuticals INC. | $15.31 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.89 | 2022 | |
| Evoke Pharma, INC. | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.